Upstream Bio (UPB) Operating Leases (2024 - 2026)

Upstream Bio (UPB) posted quarterly Operating Leases of $390000.0 for Q1 2026, down 60.69% year-over-year from $992000.0 in Q1 2025, and down 28.96% quarter-over-quarter from $549000.0 in Q4 2025.

Upstream Bio (UPB) Operating Leases (2024 - 2026) Analysis & Trends

Upstream Bio's Operating Leases history runs 3 years deep, the most recent figure standing at $390000.0 for Q1 2026.

  • In Q1 2026, Operating Leases fell 60.69% year-over-year to $390000.0; the TTM figure through Mar 2026 stood at $390000.0 (down 60.69% YoY), while the FY2025 annual figure was $549000.0, down 51.42% from the prior year.
  • Operating Leases for Q1 2026 stood at $390000.0, down from $549000.0 in the prior quarter.
  • The five-year high for Operating Leases was $1.3 million in Q3 2024, with the low at $390000.0 in Q1 2026.
  • The 3-year median for Operating Leases is $849000.0 (2025), against an average of $839428.6.
  • The sharpest annual moves came in 2025 and 2026: Operating Leases plunged 44.34% in 2025, then tumbled 60.69% in 2026.
  • Upstream Bio's Operating Leases stood at $1.1 million in 2024, then sank by 51.42% to $549000.0 in 2025, then retreated by 28.96% to $390000.0 in 2026.
  • Business Quant data shows UPB's Operating Leases at $390000.0 in Q1 2026, $549000.0 in Q4 2025, and $703000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Upstream Bio 387.23 Mn 387.23 Mn -3.29 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 226,000.00
Mar 31, 2026 390,000.00
Dec 31, 2025 549,000.00
Sep 30, 2025 703,000.00
Jun 30, 2025 849,000.00
Mar 31, 2025 992,000.00
Dec 31, 2024 1.13 Mn
Sep 30, 2024 1.26 Mn